Semma Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $937M

Semma Therapeutics General Information

Description

Operator of a cell therapy and biotechnology company intended to develop transformative therapy with the curative use of stem cells in regenerative medicines. The company specializes in developing cell-based therapies for type 1 diabetes patients which traditionally require the use of an invasive insulin pump or multiple daily insulin injections combining proprietary cells with a state-of-the-art device, thereby eliminating the use of insulin injections and providing a functional cure for patients with diabetes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 100 Technology Square
  • Floor 3
  • Cambridge, MA 02139
  • United States
+1 (857) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Semma Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 10-Oct-2019 $937M 00000 00000 Completed Generating Revenue
4. Early Stage VC (Series B) 30-Nov-2017 00000 00000 Completed Startup
3. Grant 12-Sep-2016 000 0000 Completed Startup
2. Early Stage VC (Series A) 24-Mar-2015 $44M $44M 000.00 Completed Startup
1. Spin-Off 01-Dec-2014 Completed Startup
To view Semma Therapeutics’s complete valuation and funding history, request access »

Semma Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Semma Therapeutics’s complete cap table history, request access »

Semma Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a cell therapy and biotechnology company intended to develop transformative therapy with the curative use of
Biotechnology
Cambridge, MA
00000
00000 0000-00-00
000000&0 00000

000000

ation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure d
0000000000000
South San Francisco, CA
00 As of 0000
00000
00000 0000-00-00
00000000000 00000

000000

tate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
0000000000000
London, Canada
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Semma Therapeutics Competitors (57)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurona Therapeutics Venture Capital-Backed South San Francisco, CA 00 00000 00000000000 00000
Sernova Corporation London, Canada 00 000.00 000000000 000.00
Seraxis Venture Capital-Backed Germantown, MD 00 000.00 0000000000 0 000.00
NeuroNascent Venture Capital-Backed Clarksville, MD 0 00.000 00000000000
Gelesis Formerly VC-backed Boston, MA 00 00000 000000&0
You’re viewing 5 of 57 competitors. Get the full list »

Semma Therapeutics Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
6 Dimensions Capital Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
California Institute for Regenerative Medicine Government 000 0000 000000 0
Cowen Healthcare Investments Venture Capital Minority 000 0000 000000 0
Eight Roads Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Semma Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CytoSolv 16-Nov-2015 0000000000 Biotechnology 0000000 0
To view Semma Therapeutics’s complete acquisitions history, request access »

Semma Therapeutics FAQs

  • When was Semma Therapeutics founded?

    Semma Therapeutics was founded in 2014.

  • Who is the founder of Semma Therapeutics?

    Felicia Pagliuca Ph.D, Robert Millman JD, and Douglas Melton Ph.D are the founders of Semma Therapeutics.

  • Where is Semma Therapeutics headquartered?

    Semma Therapeutics is headquartered in Cambridge, MA.

  • What industry is Semma Therapeutics in?

    Semma Therapeutics’s primary industry is Biotechnology.

  • Is Semma Therapeutics a private or public company?

    Semma Therapeutics is a Private company.

  • What is the current valuation of Semma Therapeutics?

    The current valuation of Semma Therapeutics is 00000.

  • What is Semma Therapeutics’s current revenue?

    The current revenue for Semma Therapeutics is 000000.

  • How much funding has Semma Therapeutics raised over time?

    Semma Therapeutics has raised $158M.

  • Who are Semma Therapeutics’s investors?

    6 Dimensions Capital, ARCH Venture Partners, California Institute for Regenerative Medicine, Cowen Healthcare Investments, and Eight Roads are 5 of 14 investors who have invested in Semma Therapeutics.

  • Who are Semma Therapeutics’s competitors?

    Neurona Therapeutics, Sernova, Seraxis, NeuroNascent, and Gelesis are some of the 57 competitors of Semma Therapeutics.

  • When was Semma Therapeutics acquired?

    Semma Therapeutics was acquired on 10-Oct-2019.

  • Who acquired Semma Therapeutics?

    Semma Therapeutics was acquired by Vertex Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »